(THREAD) follow-up to poll regarding whether DSMB members should be blinded to treatment assignments in RCT for interim analyseshttps://twitter.com/ADAlthousePhD/status/1085163835928006656 …
One possible reason: DSMB isn't a universally used acronym, I'd never seen it and had to look up. People might've thought you just meant regular analysis
-
-
Definitely a progression of late from DSMB to just DMC - in part in support of
@ADAlthousePhD take here that DMCs need to see all data — not just safety. So yes I’m saying DMCs need to see unblinded accumulating efficacy data too in order to best perform their taskThanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.